Form 4: Director Brown Boosts BDX Stake with RSU Award
Insider Transaction Report
Becton Dickinson Director William M. Brown reported the acquisition of 1,098 common stock units through a restricted stock award.
Summary
- William M. Brown, a Director of Becton Dickinson & Co (BDX), acquired 1,098 shares of common stock.
- The acquisition occurred on January 27, 2026, at a price of $0 per share.
- These shares represent restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
- Following this transaction, Brown beneficially owns 4,663 shares, which includes units acquired through dividend investment since the last report.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive signal due to increased insider ownership, albeit through a routine compensation award rather than an open market purchase, which typically carries a stronger signal.
Positives
- Increased insider ownership by a Director, which can signal confidence in the company's future.
- The award is part of an established equity-based compensation plan, aligning management interests with shareholders.
Future Outlook
The filing does not contain forward-looking statements or guidance regarding the company's future performance.
Management Comments
- Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
- Includes units acquired through dividend investment since the last report filed by the reporting person.
Industry Context
StockSavvy.ai notes that equity-based compensation, such as restricted stock units, is a common practice across the healthcare and medical technology industries. This aligns director incentives with long-term company performance, a standard governance practice.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) as part of director compensation is a standard practice in large-cap medical technology companies like Medtronic, Abbott Laboratories, and Johnson & Johnson, aiming to align director interests with shareholder value over time.
- A $0 acquisition price for RSUs is typical, as these awards represent a grant of shares that vest over time, rather than an open market purchase.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Award of restricted stock units to a director under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. | 01/27/2026 | Reinforces alignment of director's interests with long-term shareholder value through equity ownership. |
Related Party Transactions
- Acquisition of 1,098 common stock units by Director William M. Brown from Becton, Dickinson and Company as part of an equity compensation plan.
Stakeholder Impact
- Shareholders: Increased insider ownership may be viewed positively as it aligns director incentives with shareholder interests.
- Employees: The transaction is part of an equity compensation plan, which can be a component of overall employee and director remuneration strategies.
Next Steps
- The restricted stock units will likely vest over a specified period, as per the terms of the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
Key Dates
| Date | Description |
|---|---|
| 01/27/2026 | Date of transaction (acquisition of restricted stock units) |
| 01/29/2026 | Date Form 4 was signed by power of attorney |
Keywords
Becton Dickinson, BDX, Form 4, Insider Transaction, Restricted Stock Units, Director Compensation, Equity Award
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.